Trial Profile
Clinical and genetic factors on response to treatment with Tocilizumab in patients with rheumatoid arthritis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Jan 2018
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Biomarker; Therapeutic Use
- 23 Jan 2018 New trial record